This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
November 02, 2021
Pulmonx Reports Third Quarter 2021 Financial Results
November 02, 2021
Xeris Biopharma to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 10, 2021
November 02, 2021
Vicore’s C21 reduces long-term lung injury after COVID-19 in the ATTRACT Phase 2 extension study
October 28, 2021
BONESUPPORT HOLDING AB (publ) – Interim Report Q3 2021 Invitation to conference call and webcast
October 27, 2021
HelloBetter raises six million Euros to build the category leader in digital mental health
October 27, 2021
Targovax ASA: Invitation to presentation of Targovax’s third quarter 2021 results, Thursday 4 November
October 26, 2021
Pulmonx to Report Third Quarter 2021 Financial Results on November 2, 2021
October 25, 2021
Lancet’s EClinicalMedicine publishes phase 2 data on C21 in COVID-19
October 22, 2021
Targovax invites to webcast presentation on Xtrainvestor
October 22, 2021
Oncopeptides withdraws Pepaxto® in US, scale down organization and focus on R&D